Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme - No Study Results Posted

Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (ACT III)

This study is ongoing, but not recruiting participants.

Study NCT00458601 Information provided by Celldex Therapeutics

First Received: April 10, 2007 Last Updated: November 15, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	December 2011
Primary Completion Date:	November 2010 (Final data collection date for primary outcome measure)
Certification - "Seeking Initial Approval":	Submission Date: June 24, 2010